E
Envoy Medical, Inc. (COCH)
NCM – Real Time Price. Currency in USD
0.65
-0.04 (-5.83%)
At close: Mar 27, 2026, 4:00 PM EDT
0.63
-0.03 (-3.91%)
After-hours: Mar 27, 2026, 7:22 PM EDT
Get all premium features to the best stock analysis tool
NCM – Real Time Price. Currency in USD
0.65
-0.04 (-5.83%)
At close: Mar 27, 2026, 4:00 PM EDT
0.63
-0.03 (-3.91%)
After-hours: Mar 27, 2026, 7:22 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.64 | 3.40 | 4.0 | |
| Quick ratio | 0.46 | 2.52 | 4.0 | |
| Debt to Equity | N/A | 1.11 | 1.0 | |
| Debt to Assets | 0.12 | 1.58 | 8.0 | |
| Interest coverage | -12.12 | 4.33 | 1.0 | |
| Weighted average score | 3.6 | |||
| METRIC | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | 237K | 316K | 225K | 208K |
| Gross Profit | N/A | -336K | -473K | -517K | -612K |
| Operating Income | -5M | -9M | -18M | -19M | -20M |
| Net Income | -252K | -16M | -30M | -22M | -23M |
| EBITDA | -5M | -9M | -18M | -19M | -20M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -28.57 | 54.72 | 5.5 |
| Next quarter | -13.04 | 13.79 | 4.5 |
| Current year | -11.11 | 20.13 | 5.5 |
| Next year | 0 | 20.17 | 5.5 |
| Weighted average score | 5.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -46.14 | -13.91 | -9.37 | 2.91 | 1.8 |
| Y/Y | -24.99 | -8.75 | 5.41 | -26.55 | 2.0 |
| 3y average | 334.51 | -2096.93 | N/A | -93.08 | 3.3 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 2.0 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $3.6M significantly exceed its total debt $946.0K, ensuring strong financial flexibility
Total current liabilities $9.0M surpass Total current assets $5.8M, signaling liquidity issues
Debt-to-equity ratio (-0.1) is well below the industry average (1.1), showcasing prudent financial management
Interest coverage ratio (-12.1x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$4.3M limits the company's ability to reinvest or pay down debt